For nearly 20 years, CutisPharma's singular focus has been to address the needs of patients who are unable to take capsules or tablets, such as children and the elderly, for whom no therapy is commercially available.
Mr. Whooley joined CutisPharma in September 2014 as controller and heading the company’s finance and accounting teams. Mr. Whooley has over 25 years of accounting, financial, and operational business experience. Prior to joining CutisPharma, Mr. Whooley held Controller positions at AliasWire, Inc., Bionaut Pharmaceuticals and Seaflower Ventures. Mr. Whooley holds an M.S. in Finance from Suffolk University and a B.S. from Bentley College.